MI Sign Up for eTOC Alerts
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Dempsey, P. J.
Right arrow Articles by Raines, E. W.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Dempsey, P. J.
Right arrow Articles by Raines, E. W.
Molecular Interventions 2:136-141 (2002)
© 2002 American Society of Pharmacology and Experimental Therapeutics



Viewpoint

Emerging Roles of TACE as a Key Protease in ErbB Ligand Shedding

Peter J. Dempsey1, Kyle Garton2 and Elaine W. Raines2

1 Pacific Northwest Research Institute, Seattle, WA 98122, USA and
2 Department of Pathology, Harborview Medical Center, University of Washington, Seattle, WA, 98104, USA

SUMMARY

Sunnarborg et al. have published how tumor necrosis factor-{alpha} converting enzyme (TACE) can control the availability of transforming growth factor-{alpha}—a natural ligand for epidermal growth factor receptors (EGFRs)—for EGFRs located at the cell surface. Dempsey, Garton, and Raines examine the ramifications of TACE-dependent proteolytic cleavage of membrane-bound ligands on paracrine, juxtacrine, and autocrine signaling.




This article has been cited by other articles:


Home page
J. Biol. Chem.Home page
N. Ali and V. Knauper
Phorbol Ester-induced Shedding of the Prostate Cancer Marker Transmembrane Protein with Epidermal Growth Factor and Two Follistatin Motifs 2 Is Mediated by the Disintegrin and Metalloproteinase-17
J. Biol. Chem., December 28, 2007; 282(52): 37378 - 37388.
[Abstract] [Full Text] [PDF]


Home page
Mol. Interv.Home page
L. M. Graves, J. Han, and H. S. Earp III
Transactivation of the EGF Receptor: Is the PDGF Receptor an Unexpected Accomplice?
Mol. Interv., July 1, 2002; 2(4): 208 - 212.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
ASPET Journals Pharmacological Reviews Drug Metabolism and Disposition
Molecular Interventions Molecular Pharmacology J Pharmacology and Exp Therapeutics
Copyright © 2002 by the American Society for Pharmacology and Experimental Therapeutics.